首页 | 本学科首页   官方微博 | 高级检索  
检索        

脾内转染白细胞介素-2和/或12基因增强接种肝癌大鼠T细胞功能研究
引用本文:尤天庚,杨家和,沈达明,陈小云,周颍奇,王宏顺,范瑞芳,钱其军,吴孟超.脾内转染白细胞介素-2和/或12基因增强接种肝癌大鼠T细胞功能研究[J].中华实验外科杂志,2004,21(12):1450-1451.
作者姓名:尤天庚  杨家和  沈达明  陈小云  周颍奇  王宏顺  范瑞芳  钱其军  吴孟超
作者单位:200438,上海,第二军医大学东方肝胆外科医院
基金项目:国家自然科学基金 (30 2 71 4 76,39970 838),上海市科技攻关重点基金 (0 341 1 9837)
摘    要:目的 探讨脾内直接注射白细胞介素IL 2、12基因对血IL 2和IL 12 ,以及T细胞活性的影响。方法 构建IL 2和或IL 12基因的逆转录病毒载体。含IL 2和或IL 12基因的包装细胞于不同时间进行脾内注射转染脾细胞。比较大鼠血IL 2和IL 12浓度、T细胞活性和毒性反应。结果 IL单基因治疗后血清IL 2或IL 12明显增高。IL 2 /IL 12联合基因组中血清IL 2和IL 12增加较单基因组显著。病理示肝癌组织中淋巴细胞浸润明显增多。IL治疗组治疗后 7d ,T细胞活性较对照组显著增高 (P <0 .0 5 )。联合基因组治疗后 7d ,T细胞功能较IL单基因组增强(P <0 .0 5 )。结论 脾内直接注射IL 2和或IL 12基因可增强T细胞活性 ,IL联合基因治疗优于IL单基因。

关 键 词:白介素-2  白介素12  T细胞    肝细胞  基因治疗
修稿时间:2004年8月19日

Enhancement of T cell activity by transfecting IL-2 and/or IL-12 genes into spleen in implanted liver cancer rats
YOU Tian Geng,YANG Jia He,SHEN Da Ming,et al..Enhancement of T cell activity by transfecting IL-2 and/or IL-12 genes into spleen in implanted liver cancer rats[J].Chinese Journal of Experimental Surgery,2004,21(12):1450-1451.
Authors:YOU Tian Geng  YANG Jia He  SHEN Da Ming  
Institution:YOU Tian Geng,YANG Jia He,SHEN Da Ming,et al.Eastern Hepatobilliary Surgery Hospital,Second Military Medical University,Shanghai 200438,China
Abstract:Objective To study the effects of interleukin 12 (IL 12) and interleukin 2 (IL 2) genes injected intrasplenically on serum ILs and T cell activity in liver cancer.Methods The retroviral vectors encoding IL 2 and/or IL 12 genes were constructed.The packaging cell transfected by the vectors (IL genes) was injected directly into rat spleen at different time points.The serum IL 2 and IL 12,T cell activity and toxic effects were investigated.Results After treatment with IL alone for 7days,the serum IL 2 or IL 12 was increased markedly.In the group of combined use of IL 2/IL 12 genes,the levels of serum IL 2 and IL 12 were higher than those in group of IL alone.The pathological study showed that a large number of lymphocytes were infiltrated into liver tissues in the group of combined use of IL 2/IL 12 genes.As compared with control,T cell activity was increased markedly after treatment with IL for 7 days (P<0.05).After combined treatment with IL 2/ 12 gene for 7 days,T cells were activated significantly as compared with those in group of IL alone ( P <0.05).Conclusion IL 2 and/or IL 12 genes injected directly into spleen increase the T cell activity.Combined treatment with IL 2/IL 12 genes is superior to that of IL gene alone.
Keywords:Interleukin-2  Interleukin-12  T cell  Carcinoma  hepatocellular  Gene therapy
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号